How Is the Trump Administration’s Plan to Lower Drug Prices Going?

Posted on

The Department of Health and Human Services (HHS) has released a report, “100 Days of Action on the American Patient First Blueprint,” and a factsheet about the Trump Administration’s drug price blueprint. The report notes that: 

  • 15 drug companies responded to the Trump blueprint. 
  • 2 have lowered the cost of prescription drugs.
  • 13 committed to price freezes for the remainder of 2018.
  • 4 canceled planned price increases. 

You can read more here.  

HHS releases report analyzing first 100 days following the release of the President’s blueprint to lower drug prices; 15 drug companies respond. ASCRS news release  August 2018.  http://ascrs.org/node/32522.  

Related Articles
2020 Reimbursement Changes for Endoscopic Cyclophotocoagulation with Cataract Surgery
Jan 10, 2020
Proposed Ophthalmology-Related Coding Changes for 2020
Dec 20, 2019
Application of E/M Codes for Postoperative Visits is Top Priority for the Academy
Oct 14, 2019
Click to access the login or register cheese